SCHEDULE 13G/A: Armistice Capital and Steven Boyd Maintain 4.99% Stake in Palatin Technologies

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, disclosing a beneficial ownership of 4.99% of Palatin Technologies Inc.'s common stock as of March 31, 2025.

Summary

• Armistice Capital, LLC, a Delaware-based investment adviser, and Steven Boyd, a U.S. citizen and managing member of Armistice Capital, are the reporting persons.
• The filing pertains to their beneficial ownership of Common Stock, par value $0.01 per share, of PALATIN TECHNOLOGIES INC.
• As of March 31, 2025, the reporting persons collectively beneficially own 1,278,054 shares, which represents 4.99% of the issuer's class of securities.
• Armistice Capital, LLC, as the investment manager of Armistice Capital Master Fund Ltd., exercises shared voting and dispositive power over these securities.
• Steven Boyd, as the managing member of Armistice Capital, is also deemed to beneficially own these shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Palatin Technologies Inc.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a routine disclosure of a significant, but passive, institutional stake. It does not contain negative news, and the presence of an institutional investor can be seen as a positive signal of confidence.

Positives

• The presence of a significant institutional investor like Armistice Capital holding a substantial stake can be viewed as a vote of confidence in Palatin Technologies Inc.
• The filing explicitly states that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control, indicating a passive investment approach.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding Palatin Technologies Inc.'s future performance or strategic direction.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a routine disclosure of an institutional investor's passive stake in a publicly traded company, common within the financial industry for investment funds managing portfolios. It indicates Armistice Capital's continued position in Palatin Technologies, which operates in the biotechnology or pharmaceutical sector.

Comparison to Industry Standards

• This document is a standard Schedule 13G filing, which is a common regulatory requirement for investors acquiring more than 5% of a company's stock but without the intent to control or influence the company. The 4.99% stake reported is just below the 5% threshold that would typically trigger a Schedule 13D filing, which implies an intent to influence or control.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's position, which may influence investor sentiment and perception of the company's stability.

Key Dates

Keywords

Palatin Technologies Inc., Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Institutional Investor, SEC Filing